MENU
ZCMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ZCMD stock forecast, quote, news & analysis

ZHONGCHAO Inc is an offshore holding company... Show more

ZCMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for ZCMD with price predictions
Jul 13, 2026

ZCMD sees its Stochastic Oscillator climbs out of oversold territory

On July 06, 2026, the Stochastic Oscillator for ZCMD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 51 instances where the indicator left the oversold zone. In of the 51 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 06, 2026. You may want to consider a long position or call options on ZCMD as a result. In of 118 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZCMD just turned positive on June 16, 2026. Looking at past instances where ZCMD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

ZCMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZCMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZCMD entered a downward trend on July 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.094) is normal, around the industry mean (7.922). ZCMD has a moderately low P/E Ratio (0.000) as compared to the industry average of (54.426). ZCMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.303). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.005) is also within normal values, averaging (6.090).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZCMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.42B. The market cap for tickers in the group ranges from 708 to 31.97B. VEEV holds the highest valuation in this group at 31.97B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -2%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -0%. AMWL experienced the highest price growth at 19%, while ZCMD experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -39%. For the same stocks of the Industry, the average monthly volume growth was -30% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 75
Price Growth Rating: 53
SMR Rating: 88
Profit Risk Rating: 98
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
ZCMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a holding company that engages in the provision of healthcare information, education, and training services

Industry ServicestotheHealthIndustry

Profile
Details
Industry
N/A
Address
841 Yan’An Middle Road
Phone
+86 2132205987
Employees
109
Web
https://www.mdmooc.org
ZCMD sees its Stochastic Oscillator climbs out of oversold territory